{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:39:04Z","timestamp":1791859144378,"version":"4.3.4"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1097\/wnn.0b013e31802b6c34","type":"journal-article","created":{"date-parts":[[2007,3,13]],"date-time":"2007-03-13T02:57:58Z","timestamp":1173754678000},"page":"11-14","source":"Crossref","is-referenced-by-count":12,"title":["Treatment of Juvenile Parkinson Disease and the Recurrent Emergence of Pathologic Gambling"],"prefix":"10.1097","volume":"20","author":[{"given":"Rafael Ferreira","family":"Garcia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Ordacgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro V.","family":"Mendlowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel R.","family":"de Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Lucia Z.","family":"Rosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno P.","family":"Nazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo F.","family":"Fontenelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210129","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/jnnp.67.4.492","article-title":"Range of neuropsychiatric disturbances in patients with Parkinson's disease","volume":"67","author":"Aarsland","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R2-3-20210129","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00415-004-0483-3","article-title":"Psychiatric aspects of Parkinson's disease","volume":"251","author":"Schrag","year":"2004","journal-title":"J Neurol"},{"key":"R3-3-20210129","article-title":"Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Text Revision ed","year":"2000"},{"key":"R4-3-20210129","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1023\/A:1021271029163","article-title":"Genetics of pathological gambling","volume":"19","author":"Ibanez","year":"2003","journal-title":"J Gambl Stud"},{"key":"R5-3-20210129","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/archneur.62.9.noc50009","article-title":"Pathological gambling caused by drugs used to treat Parkinson disease","volume":"62","author":"Dodd","year":"2005","journal-title":"Arch Neurol"},{"key":"R6-3-20210129","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/1531-8257(200009)15:5<869::AID-MDS1016>3.0.CO;2-I","article-title":"Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment?","volume":"15","author":"Molina","year":"2000","journal-title":"Mov Disord"},{"key":"R7-3-20210129","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/1520-6394(2000)11:4<185::AID-DA8>3.0.CO;2-H","article-title":"Pathological gambling behaviour: emergence secondary to treatment of Parkinson's disease with dopaminergic agents","volume":"11","author":"Seedat","year":"2000","journal-title":"Depress Anxiety"},{"key":"R8-3-20210129","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00002826-200105000-00009","article-title":"Pathologic gambling in patients with Parkinson's disease","volume":"24","author":"Gschwandtner","year":"2001","journal-title":"Clin Neuropharmacol"},{"key":"R9-3-20210129","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1212\/01.WNL.0000076478.45005.EC","article-title":"Pathological gambling associated with dopamine agonist therapy in Parkinson's disease","volume":"61","author":"Driver-Dunckley","year":"2003","journal-title":"Neurology"},{"key":"R10-3-20210129","first-page":"441","article-title":"Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine [in French]","volume":"159","author":"Montastruc","year":"2003","journal-title":"Rev Neurol Paris"},{"key":"R11-3-20210129","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s10072-004-0238-z","article-title":"Pathological gambling in two patients on dopamine replacement therapy for Parkinson's disease","volume":"25","author":"Avanzi","year":"2004","journal-title":"Neurol Sci"},{"key":"R12-3-20210129","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/mds.10625","article-title":"Disabling repetitive behaviors in Parkinson's disease","volume":"19","author":"Kurlan","year":"2004","journal-title":"Mov Disord"},{"key":"R13-3-20210129","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00702-003-0027-5","article-title":"Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatum","volume":"110","author":"Gerlach","year":"2003","journal-title":"J Neural Transm"},{"key":"R14-3-20210129","doi-asserted-by":"crossref","first-page":"17113","DOI":"10.1073\/pnas.012260599","article-title":"A possible substrate for dopamine-related changes in mood and behavior: Prefrontal and limbic effects of a D3-preferring dopamine agonist","volume":"99","author":"Black","year":"2002","journal-title":"PNAS"},{"key":"R15-3-20210129","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/01.wco.0000194141.56429.3c","article-title":"Decision-making and impulse control after frontal lobe injuries","volume":"18","author":"Bechara","year":"2005","journal-title":"Curr Opin Neurol"},{"key":"R16-3-20210129","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1136\/jnnp.2003.024885","article-title":"Novelty seeking and harm avoidance in Parkinson's disease: effects of asymmetric dopamine deficiency","volume":"75","author":"Tomer","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R17-3-20210129","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.parkreldis.2004.10.007","article-title":"Defining the Parkinson's disease phenotype: initial symptoms and baseline characteristics in a clinical cohort","volume":"11","author":"Uitti","year":"2005","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Cognitive and Behavioral Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/WNN.0b013e31802b6c34","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:33:33Z","timestamp":1786034013000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00146965-200703000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/wnn.0b013e31802b6c34","relation":{},"ISSN":["1543-3633"],"issn-type":[{"value":"1543-3633","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}